Arash Mostaghimi, MD, MPA, MPH, director of the inpatient dermatology consult service at Brigham & Women's Hospital, discusses the utility of deuruxolitinib for treating moderate to severe alopecia ...
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata ... eyelashes, and eyebrows. Lilly’s drug was turned down ...
This significant development follows a breakthrough in identifying a candidate drug for alopecia areata through Shaperon’s proprietary AI-based drug development platform, AIDEN. The candidate ...